• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Fungal Fog in Viral Storms: Necessity for Rigor in Aspergillosis Diagnosis and Research.

作者信息

Feys Simon, Hoenigl Martin, Gangneux Jean-Pierre, Verweij Paul E, Wauters Joost

机构信息

Medical Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.

Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.

出版信息

Am J Respir Crit Care Med. 2024 Mar 15;209(6):631-633. doi: 10.1164/rccm.202310-1815VP.

DOI:10.1164/rccm.202310-1815VP
PMID:37972350
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10945057/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f12/10945057/201f1662045d/rccm.202310-1815VPf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f12/10945057/201f1662045d/rccm.202310-1815VPf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f12/10945057/201f1662045d/rccm.202310-1815VPf1.jpg

相似文献

1
Fungal Fog in Viral Storms: Necessity for Rigor in Aspergillosis Diagnosis and Research.病毒风暴中的真菌迷雾：曲霉病诊断与研究中严谨性的必要性。
Am J Respir Crit Care Med. 2024 Mar 15;209(6):631-633. doi: 10.1164/rccm.202310-1815VP.
2
Issues in the diagnosis and treatment of invasive aspergillosis. Introduction.侵袭性曲霉病的诊断与治疗问题。引言。
Manag Care Interface. 2004;Suppl B:5-6.
3
[Invasive aspergillosis of the lung].[肺侵袭性曲霉病]
Pneumonol Alergol Pol. 1997;65(3-4):283-7.
4
[Management of invasive candidiasis and aspergillosis in adults].[成人侵袭性念珠菌病和曲霉病的管理]
Rev Pneumol Clin. 2004 Nov;60(5 Pt 1):289-93.
5
[Disseminated aspergillosis in chronic respiratory insufficiency. Diagnosis and treatment].[慢性呼吸功能不全中的播散性曲霉病。诊断与治疗]
Med Clin (Barc). 1984 Mar 17;82(10):451-3.
6
[Diagnosis, treatment and prevention of invasive aspergillosis. A priority target in hospital units].[侵袭性曲霉病的诊断、治疗与预防。医院科室的重点目标]
Pathol Biol (Paris). 1994 Sep;42(7):629-31.
7
[Childhood pulmonary aspergillosis: report of three cases].[儿童肺曲霉病：三例报告]
Zhongguo Dang Dai Er Ke Za Zhi. 2010 May;12(5):401-3.
8
Fungal pneumonia (Part 4): invasive pulmonary aspergillosis.真菌性肺炎（第4部分）：侵袭性肺曲霉病
Chest. 1981 Aug;80(2):220-5. doi: 10.1378/chest.80.2.220.
9
Progressive chronic pulmonary aspergillosis: a diagnostic and therapeutic challenge.进行性慢性肺曲霉病：诊断与治疗的挑战
J R Soc Med. 1992 Dec;85(12):763-4. doi: 10.1177/014107689208501220.
10
[Invasive pulmonary aspergillosis. 6 case reports].[侵袭性肺曲霉病。6例病例报告]
Rev Clin Esp. 1985 Nov;177(8):399-405.

引用本文的文献

1
Emerging Risk Factors for Invasive Pulmonary Aspergillosis: A Narrative Review.侵袭性肺曲霉病的新兴危险因素：一项叙述性综述
J Fungi (Basel). 2025 Jul 27;11(8):555. doi: 10.3390/jof11080555.
2
Aspergillus fumigatus biology, immunopathogenicity and drug resistance.烟曲霉的生物学特性、免疫致病性及耐药性。
Nat Rev Microbiol. 2025 May 2. doi: 10.1038/s41579-025-01180-z.
3
Impact of physician awareness and microbiological examination on incidence of COVID-19-associated pulmonary aspergillosis: a retrospective study.医生认知和微生物学检查对新型冠状病毒肺炎相关肺曲霉病发病率的影响：一项回顾性研究

本文引用的文献

1
Viral-associated Pulmonary Aspergillosis: Have We Finally Overcome the Debate of Colonization versus Infection?病毒相关性肺曲霉病：我们终于解决定植与感染的争论了吗？
Am J Respir Crit Care Med. 2023 Aug 1;208(3):230-231. doi: 10.1164/rccm.202306-1022ED.
2
A Pathology-based Case Series of Influenza- and COVID-19-associated Pulmonary Aspergillosis: The Proof Is in the Tissue.基于病理学的流感和 COVID-19 相关肺曲霉病病例系列：证据就在组织中。
Am J Respir Crit Care Med. 2023 Aug 1;208(3):301-311. doi: 10.1164/rccm.202208-1570OC.
3
COVID-19-associated fungal infections.
BMC Pulm Med. 2025 Apr 25;25(1):198. doi: 10.1186/s12890-025-03671-4.
4
An Observational Cohort Study of Bronchoalveolar Lavage Fluid Galactomannan and Culture Positivity in Patients Requiring Mechanical Ventilation.一项针对需要机械通气患者的支气管肺泡灌洗液体半乳甘露聚糖及培养阳性率的观察性队列研究。
Open Forum Infect Dis. 2025 Feb 15;12(3):ofaf090. doi: 10.1093/ofid/ofaf090. eCollection 2025 Mar.
5
Viral reactivations and fungal infections in nonresolving acute respiratory distress syndrome.持续性急性呼吸窘迫综合征中的病毒再激活和真菌感染
Eur Respir Rev. 2025 Feb 19;34(175). doi: 10.1183/16000617.0153-2024. Print 2025 Jan.
6
Epidemiology of Coronavirus Disease 2019-Associated Fungal Infections in the Intensive Care Unit: A Single-Center Retrospective Study.重症监护病房中2019冠状病毒病相关真菌感染的流行病学：一项单中心回顾性研究。
Mycopathologia. 2025 Jan 21;190(1):16. doi: 10.1007/s11046-025-00928-8.
7
Posaconazole for Prevention of COVID-19-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients: A European Multicentre Case-Control Study (POSACOVID).泊沙康唑预防机械通气患者新型冠状病毒肺炎相关肺曲霉病：一项欧洲多中心病例对照研究（POSACOVID）
Mycoses. 2025 Jan;68(1):e70023. doi: 10.1111/myc.70023.
8
COVID-19 associated pulmonary aspergillosis in critically-ill patients - authors' reply.危重症患者的新型冠状病毒肺炎相关肺曲霉病——作者回复
Ann Intensive Care. 2024 Jul 15;14(1):112. doi: 10.1186/s13613-024-01320-3.
9
Antifungals in Patients With Extracorporeal Membrane Oxygenation: Clinical Implications.接受体外膜肺氧合治疗患者的抗真菌药物：临床意义
Open Forum Infect Dis. 2024 May 8;11(6):ofae270. doi: 10.1093/ofid/ofae270. eCollection 2024 Jun.
10
Profiling Bacteria in the Lungs of Patients with Severe Influenza Versus COVID-19 with or without Aspergillosis.分析重症流感与 COVID-19 患者肺部细菌特征：是否合并曲霉病。
Am J Respir Crit Care Med. 2024 Nov 15;210(10):1230-1242. doi: 10.1164/rccm.202401-0145OC.
COVID-19 相关真菌感染。
Nat Microbiol. 2022 Aug;7(8):1127-1140. doi: 10.1038/s41564-022-01172-2. Epub 2022 Aug 2.
4
Coronavirus Disease 2019-Associated Pulmonary Aspergillosis: Reframing the Debate.2019冠状病毒病相关肺曲霉病：重新审视这场辩论
Open Forum Infect Dis. 2022 Mar 3;9(5):ofac081. doi: 10.1093/ofid/ofac081. eCollection 2022 May.
5
Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis.新型冠状病毒肺炎相关肺曲霉病诊断与临床管理特别工作组报告
Intensive Care Med. 2021 Aug;47(8):819-834. doi: 10.1007/s00134-021-06449-4. Epub 2021 Jun 23.
6
Posaconazole for prevention of invasive pulmonary aspergillosis in critically ill influenza patients (POSA-FLU): a randomised, open-label, proof-of-concept trial.泊沙康唑预防危重症流感患者侵袭性肺曲霉病（POSA-FLU）的随机、开放标签、概念验证试验。
Intensive Care Med. 2021 Jun;47(6):674-686. doi: 10.1007/s00134-021-06431-0. Epub 2021 May 29.
7
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.定义和管理新型冠状病毒肺炎相关肺曲霉病：2020年欧洲临床微生物与感染性疾病学会/国际人类与动物真菌学会研究和临床指南共识标准
Lancet Infect Dis. 2021 Jun;21(6):e149-e162. doi: 10.1016/S1473-3099(20)30847-1. Epub 2020 Dec 14.
8
Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion.重症监护病房患者流感相关肺曲霉病综述及病例定义建议：专家意见
Intensive Care Med. 2020 Aug;46(8):1524-1535. doi: 10.1007/s00134-020-06091-6. Epub 2020 Jun 22.
9
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.重症监护病房中因严重流感入院的患者侵袭性曲霉菌病：一项回顾性队列研究。
Lancet Respir Med. 2018 Oct;6(10):782-792. doi: 10.1016/S2213-2600(18)30274-1. Epub 2018 Jul 31.
10
A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients.一种用于诊断危重症患者侵袭性肺曲霉病的临床算法。
Am J Respir Crit Care Med. 2012 Jul 1;186(1):56-64. doi: 10.1164/rccm.201111-1978OC. Epub 2012 Apr 19.